The Flinders Sensitive Line of rats, a rat model of depression, has elevated brain glucose utilization when compared to normal rats and the Flinders Resistant Line of rats

Neurochemistry International

Volumn 55, Issue 7, 2009, Pages 655-661

  Kanemaru, Kazuya ^a   Diksic, Mirko ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Autoradiography; Depression model; Imaging; Na ve rats

Indexed keywords

GLUCOSE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; BRAIN CORTEX; BRAIN METABOLISM; BRAIN STEM; CHEMICAL PARAMETERS; CONTROLLED STUDY; DEPRESSION; GLUCOSE UTILIZATION; LIMBIC CORTEX; MALE; MOTOR CORTEX; NEUROCHEMISTRY; NONHUMAN; PINEAL BODY; PRIORITY JOURNAL; RAT; RAT STRAIN; SPRAGUE DAWLEY RAT; STRAIN DIFFERENCE;

ANIMALS; AUTORADIOGRAPHY; BRAIN CHEMISTRY; CHOLINESTERASE INHIBITORS; DEPRESSION; DOPAMINE; GLUCOSE; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOFLUROPHATE; LIMBIC SYSTEM; MALE; OXYGEN CONSUMPTION; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; VENTRAL TEGMENTAL AREA;

ANIMALIA; RATTUS;

EID: 69349094173     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.06.011     Document Type: Article

References (51)

1. Baxter Jr. L.R., Phelps M.E., Mazziotta J.C., Schwartz J.M., Gerner R.H., Selin C.E., and Sumida R.M. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch. Gen. Psychiatry 42 5 (1985) 441-447
2. Benjamini Y., Drai D., Elmer G., Kafkafi N., and Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125 (2001) 279-284
3. Berney A., Nishikawa M., Benkelfat C., Debonnel G., Gobbi G., and Diksic M. An index of 5-HT synthesis changes during early antidepressant treatment: α-[11C]methyl-L-tryptophan PET study. Neurochem. Int. 52 4-5 (2008) 701-708
4. Bhagwagar Z., Wylezinska M., Taylor M., Jezzard P., Matthews P.M., and Cowen P.J. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am. J. Psychiatry 161 2 (2004) 368-370
5. Dewey S.L., Smith G.S., Logan J., Alexoff D., Ding Y.S., King P., Pappas N., Brodie J.D., and Ashby Jr. C.R. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J. Neurosci. 15 1 (Pt 2) (1995) 821-829
6. Dremencov E., Gispan-Herman I., Rosenstein M., Mendelman A., Overstreet D.H., Zohar J., and Yadid G. The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 28 1 (2004) 141-147
7. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., and Raichle M.E. A functional anatomical study of unipolar depression. J. Neurosci. 12 9 (1992) 3628-3641
8. Drevets W.C., Price J.L., Bardgett M.E., Reich T., Todd R.D., and Raichle M.E. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol. Biochem. Behav. 71 3 (2002) 431-447
9. Drevets W.C., Ongür D., and Price J.L. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol. Psychiatry 3 3 (1998) 220-226 (190-1, review)
10. Fava M., and Kendler K.S. Major depressive disorder. Neuron 28 (2000) 335-341
11. Genud R., Merenlender A., Gispan-Herman I., Maayan R., Weizman A., and Yadid G. DHEA lessens depressive-like behavior via GABA-ergic modulation of the esolimbic system. Neuropsychopharmacology 34 3 (2009) 577-584
12. Goochee C., Rasband W., and Sokoloff L. Computerized densitometry and color coding of [14C]deoxyglucose autoradiographs. Ann. Neurol. 7 (1980) 359-370
13. Grome J.J., and Harper A.M. Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists. J. Neurochem. 46 1 (1986) 117-124
14. Hasegawa S., Nishi K., Watanabe A., Overstreet D.H., and Diksic M. Brain 5-HT synthesis in the Flinders Sensitive Line Rat Model of depression: an autoradiographic study. Neurochem. Int. 48 (2006) 358-366
15. Hosokawa T., Momose T., and Kasai K. Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states. Prog. Neuropsychopharmacol. Biol. Psychiatry (2008) 10.1016/j.pnpbp.2008.11.014
16. Hyman S.E., and Nestler E.J. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am. J. Psychiatry 153 (1996) 151-162
17. Invernizzi R., Velasco C., Bramante M., Longo A., and Samanin R. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Neuropharmacology 36 4-5 (1997) 467-473
18. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72 1 (1992) 165-229
19. Kanemaru K., Hasegawa S., Nishi K., and Diksic M. Acute citalopram has different effects on regional 5-HT synthesis in FSL, FRL, and SDP rats: an autoradiographic evaluation. Brain Res. Bull. 77 (2008) 214-220
20. Kanemaru, et al. Chronic citalopram treatment elevates serotonin synthesis in flinders sensitive and flinders resistant lines of rats, with no significant effect on Sprague-Dawley rats. Neurochem. Int. 54 5-6 (2009) 363-371
21. Kling A.S., Metter E.J., Riege W.H., and Kuhl D.E. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. Am. J. Psychiatry 143 2 (1986) 175-180
22. Maes M., Kubera M., and Leunis J.C. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuroendocrinol. Lett. 29 1 (2008) 27-53
23. Maes M., Kubera M., and Leunis J.C. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuroendocrinol. Lett. 29 1 (2008 Feb 18) 27-53
24. Marsteller D.A., Barbarich-Marsteller N.C., Patel V.D., and Dewey S.L. Brain metabolic changes following 4-week citalopram infusion: increased 18FDG uptake and gamma-amino butyric acid levels. Synapse 61 11 (2007) 877-881
25. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., and Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156 5 (1999) 675-682
26. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., and Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol. Psychiatry 48 8 (2000) 830-843
27. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., Silva J.A., McGinnis S., Glass T.G., Martin C.C., and Fox P.T. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8 4 (1997) 1057-1061
28. McBean D.E., Ritchie I.M., Olverman H.J., and Kelly P.A. Effects of the specific serotonin reuptake inhibitor, citalopram, upon local cerebral blood flow and glucose utilisation in the rat. Brain Res. 847 1 (1999) 80-84
29. Nishi K., Kanemaru K., Hasegawa S., Watanabe A., and Diksic M. Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats. Neurochem. Int. 54 3-4 (2009) 205-214
30. Nishi K., Kanemaru K., and Diksic M. A genetic rat model of depression, Flinders sensitive line has a lower density of 5-HT1A receptors, but a higher density of 5-HT1B receptors, compared to control rats. Neurochem. Int. 54 5-6 (2009) 299-300
31. Overstreet D.H., Russell R.W., Helps S.C., and Messenger M. Selective breeding for sensitivity to anticholinesterase, DPF. Psychopharmacology 65 (1979) 15-20
32. Overstreet D.H. Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. Behav. Gen. 32 5 (2002) 335-348
33. Overstreet D.H., Friedman E., Mathé A.A., and Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci. Biobehav. Rev. 29 (2005) 739-759
34. Paxinos G., and Watson C. The Rat Brain Atlas in Stereotaxic Coordinates. Compact Third Edition (1997), Academic Press, New York
35. Rosa-Neto P., Diksic M., Okazawa H., Leyton M., Ghadirian N., Mzengeza S., Nakai A., Debonnel G., Blier P., and Benkelfat C. Measurement of brain regional α-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch. Gen. Psychiatry 61 6 (2004) 556-563
36. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46
37. Russell R.W., Overstreet D.H., Messenger M., and Helps S.C. Selective breeding for sensitivity to DFP. Generalization of effects beyond criterion variables. Pharmacol. Biochem. Behav. 17 (1982) 885-891
38. Sako K., Kato A., Diksic M., and Yamamoto L.Y. Use of short-lived 18F and long-lived 14C in double tracer autoradiography for simultaneous measurement of LCBF and LCGU. Stroke 15 (1984) 896-900
39. Schuier F., Orzi F., Suda S., Lucignani G., Kennedy C., and Sokoloff L. Influence of plasma glucose concentration on lumped constant of the deoxyglucose method: effects of hyperglycemia in the rat. J. Cerebr. Blood Flow Metab. 10 6 (1990) 765-773
40. Skelin I., Sato H., and Diksic M. Olfactory bulbectomy reduces cerebral glucose utilization: 2-[14C]deoxyglucose autoradiographic study. Brain Res. Bull. 76 5 (2008) 485-492
41. Smith G.S., Ma Y., Dhawan V., Gunduz H., Carbon M., Kirshner M., Larson J., Chaly T., Belakhleff A., Kramer E., Greenwald B., Kane J.M., Laghrissi-Thode F., Pollock B.G., and Eidelber D. Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects. Synapse 45 2 (2002) 105-112
42. Smith G.S., Kramer E., Hermann C.R., Goldberg S., Ma Y., Dhawan V., Barnes A., Chaly T., Belakhleff A., Laghrissi-Thode F., Greenwald B., Eidelberg D., and Pollock B.G. Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression. Am. J. Geriatr. Psychiatry 10 6 (2002) 715-723
43. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M.H., Patlak C.S., Pettigrew K.D., Sakurada O., and Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28 5 (1977) 897-916
44. Sokoloff L. The physiological and biochemical bases of functional brain imaging. Cogn. Neurodyn. 2 1 (2008) 1-5
45. Uytdenhoef P., Portelange P., Jacquy J., Charles G., Linkowski P., and Mendlewicz J. Regional cerebral blood flow and lateralized hemispheric dysfunction in depression. Br. J. Psychiatry 143 (1983) 128-132
46. Vaidya V.A., and Duman R.S. Depression-emerging insights from neurobiology. Br. Med. Bull. 57 (2001) 61-79
47. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr. Scand. 101 (2000) 11-20
48. Willner P., and Mitchell P.J. The validity of animal models of predisposition to depression. Behav. Pharmacol. 13 (2002) 169-188
49. Yadid G., Nakash R., Deri I., Tamar G., Kinor N., Gispan I., and Zangen A. Elucidation of the neurobiology of depression: insights from a novel genetic animal model. Prog. Neurobiol. 62 4 (2000) 353-378
50. Zangen A., Overstreet D.H., and Yadid G. High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J. Neurochem. 69 6 (1997) 2477-2483
51. Zangen A., Overstreet D.H., and Yadid G. Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment. Brain Res. 824 2 (1999) 243-250